Sort   by:  
 Page size 
UnknownDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Not available
S-EPMC12089997 | biostudies-literature
UnknownDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Not available
S-EPMC12044543 | biostudies-literature
UnknownFull Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
Not available
S-EPMC6699827 | biostudies-literature
UnknownAdaptive Randomization of Neratinib in Early Breast Cancer.
Not available
S-EPMC5259558 | biostudies-literature
UnknownAdaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Not available
S-EPMC5259561 | biostudies-literature
Sort   by:  
 Page size